The nose knows: updates in intranasal pharmacology, Part 2

Intranasal administration of medications is on the rise for both on and off label uses. Dr. Mark Donaldson, Associate Principal and Dr. Philippe Mentler Senior Consulting Director, both at Vizient join host Gretchen Brummel for two episodes, sharing details on these drugs, their actions and indications.

 

Guest speakers:
Mark Donaldson, BSP, RPH, PHARMD, FASHP, FACHE
Associate Principal
Vizient

Philippe Mentler, PHARMD, BCPS
Senior Consulting Director
Vizient

Moderator:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence

 

Show Notes:

[00:33 - 02:50] Why you would choose intra-nasal administration of an agent over some of the other non-oral or non-IV routes

[02:51 - 6:05] Some practical considerations people should be aware of, particularly when not to use these agents

[6:06 - 7:12] Some of the implications for the pediatric population

[7:13 - 12:10] What we have to look forward to in the future in this space

[12:11 - 13:46] What our frontline pharmacy staff should know about these medications

 

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Android

RSS Feed